 Michael Chen
Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 18 | 2018 | 306 | 4.210 |
Why?
| | Thrombectomy | 7 | 2018 | 41 | 2.580 |
Why?
| | Endovascular Procedures | 10 | 2018 | 63 | 2.330 |
Why?
| | Intracranial Aneurysm | 5 | 2016 | 81 | 2.310 |
Why?
| | Brain Ischemia | 9 | 2018 | 87 | 2.110 |
Why?
| | Cerebral Angiography | 5 | 2016 | 65 | 2.090 |
Why?
| | Embolization, Therapeutic | 5 | 2014 | 74 | 1.780 |
Why?
| | Intracranial Hemorrhages | 4 | 2017 | 16 | 1.590 |
Why?
| | Arteriovenous Fistula | 3 | 2016 | 7 | 1.490 |
Why?
| | Thrombolytic Therapy | 6 | 2014 | 73 | 1.410 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2016 | 11 | 1.410 |
Why?
| | Aneurysm, Ruptured | 2 | 2016 | 26 | 1.350 |
Why?
| | Arterial Occlusive Diseases | 4 | 2017 | 17 | 1.140 |
Why?
| | Cerebrovascular Disorders | 3 | 2015 | 86 | 0.880 |
Why?
| | Humans | 43 | 2018 | 26370 | 0.840 |
Why?
| | Patient Transfer | 1 | 2017 | 22 | 0.780 |
Why?
| | Stents | 4 | 2018 | 146 | 0.740 |
Why?
| | Middle Aged | 21 | 2018 | 9914 | 0.700 |
Why?
| | Informed Consent | 1 | 2015 | 25 | 0.680 |
Why?
| | Periodicals as Topic | 2 | 2015 | 37 | 0.670 |
Why?
| | Female | 25 | 2018 | 15699 | 0.670 |
Why?
| | Mandible | 2 | 2018 | 15 | 0.670 |
Why?
| | Self-Help Groups | 1 | 2014 | 8 | 0.670 |
Why?
| | Retrospective Studies | 14 | 2018 | 2701 | 0.670 |
Why?
| | Neurosurgery | 2 | 2015 | 47 | 0.670 |
Why?
| | Tomography, X-Ray Computed | 5 | 2014 | 814 | 0.660 |
Why?
| | Social Media | 1 | 2014 | 23 | 0.640 |
Why?
| | Aged | 19 | 2018 | 8724 | 0.630 |
Why?
| | Vascular Access Devices | 1 | 2013 | 9 | 0.620 |
Why?
| | Maxilla | 1 | 2013 | 2 | 0.620 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2014 | 81 | 0.610 |
Why?
| | Cerebral Arteries | 1 | 2013 | 36 | 0.600 |
Why?
| | Adult | 15 | 2018 | 8641 | 0.590 |
Why?
| | Male | 25 | 2018 | 15333 | 0.570 |
Why?
| | Aged, 80 and over | 13 | 2018 | 4444 | 0.540 |
Why?
| | Checklist | 1 | 2011 | 35 | 0.530 |
Why?
| | Tibia | 1 | 2013 | 220 | 0.520 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2010 | 5 | 0.510 |
Why?
| | Bone Transplantation | 1 | 2013 | 211 | 0.510 |
Why?
| | Intraoperative Complications | 1 | 2011 | 70 | 0.510 |
Why?
| | Estrogen Replacement Therapy | 1 | 2010 | 21 | 0.510 |
Why?
| | Device Removal | 1 | 2010 | 93 | 0.470 |
Why?
| | Polycystic Kidney Diseases | 1 | 2009 | 4 | 0.460 |
Why?
| | Connective Tissue Diseases | 1 | 2009 | 10 | 0.450 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 573 | 0.450 |
Why?
| | Migraine Disorders | 1 | 2009 | 19 | 0.450 |
Why?
| | Communicable Diseases | 1 | 2009 | 15 | 0.450 |
Why?
| | Adolescent | 7 | 2018 | 2363 | 0.440 |
Why?
| | Radiology, Interventional | 1 | 2008 | 5 | 0.420 |
Why?
| | Neuroradiography | 1 | 2008 | 3 | 0.420 |
Why?
| | Heart Defects, Congenital | 1 | 2009 | 52 | 0.420 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 45 | 0.400 |
Why?
| | Follow-Up Studies | 7 | 2018 | 1820 | 0.400 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 67 | 0.390 |
Why?
| | Inflammation | 1 | 2009 | 296 | 0.380 |
Why?
| | Neurology | 1 | 2008 | 102 | 0.370 |
Why?
| | Morbidity | 2 | 2016 | 61 | 0.350 |
Why?
| | Tissue Plasminogen Activator | 4 | 2015 | 71 | 0.350 |
Why?
| | Nanostructures | 1 | 2005 | 12 | 0.350 |
Why?
| | False Positive Reactions | 2 | 2017 | 40 | 0.350 |
Why?
| | Adenoviridae | 1 | 2005 | 34 | 0.350 |
Why?
| | Blood-Brain Barrier | 1 | 2005 | 40 | 0.340 |
Why?
| | Genetic Vectors | 1 | 2005 | 65 | 0.340 |
Why?
| | Prognosis | 4 | 2018 | 874 | 0.340 |
Why?
| | Magnetic Resonance Angiography | 2 | 2016 | 47 | 0.330 |
Why?
| | Treatment Outcome | 9 | 2018 | 3306 | 0.330 |
Why?
| | Genetic Therapy | 1 | 2005 | 88 | 0.320 |
Why?
| | Young Adult | 6 | 2018 | 1890 | 0.320 |
Why?
| | Aorta, Thoracic | 1 | 2004 | 16 | 0.320 |
Why?
| | Wounds, Nonpenetrating | 1 | 2004 | 20 | 0.310 |
Why?
| | Physical Exertion | 1 | 2002 | 9 | 0.290 |
Why?
| | Catheter Ablation | 2 | 2013 | 44 | 0.290 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 346 | 0.280 |
Why?
| | Kidney Neoplasms | 2 | 2013 | 104 | 0.270 |
Why?
| | Child | 4 | 2015 | 1375 | 0.260 |
Why?
| | Angiography, Digital Subtraction | 2 | 2016 | 12 | 0.220 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.220 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2018 | 8 | 0.220 |
Why?
| | Embolectomy | 2 | 2015 | 5 | 0.220 |
Why?
| | Cheek | 1 | 2018 | 2 | 0.220 |
Why?
| | Prognathism | 1 | 2018 | 2 | 0.220 |
Why?
| | Clinical Trials as Topic | 3 | 2015 | 368 | 0.210 |
Why?
| | Intraoperative Care | 1 | 2018 | 56 | 0.210 |
Why?
| | Radiotherapy, Intensity-Modulated | 2 | 2018 | 36 | 0.210 |
Why?
| | Fibrinolytic Agents | 3 | 2017 | 88 | 0.210 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 176 | 0.200 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2016 | 306 | 0.200 |
Why?
| | Societies, Medical | 2 | 2015 | 183 | 0.190 |
Why?
| | Evidence-Based Medicine | 2 | 2015 | 211 | 0.180 |
Why?
| | Rupture, Spontaneous | 1 | 2016 | 9 | 0.180 |
Why?
| | Subdural Effusion | 1 | 2015 | 7 | 0.180 |
Why?
| | Research Report | 1 | 2015 | 7 | 0.180 |
Why?
| | Hematoma, Subdural, Acute | 1 | 2015 | 12 | 0.180 |
Why?
| | Neurologic Examination | 1 | 2016 | 149 | 0.170 |
Why?
| | Extracellular Fluid | 1 | 2014 | 4 | 0.170 |
Why?
| | Writing | 1 | 2015 | 15 | 0.170 |
Why?
| | Research Personnel | 1 | 2015 | 20 | 0.170 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 21 | 0.170 |
Why?
| | Posterior Cerebral Artery | 1 | 2014 | 3 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2014 | 6 | 0.160 |
Why?
| | Cerebellar Neoplasms | 1 | 2014 | 7 | 0.160 |
Why?
| | Radiation Tolerance | 1 | 2014 | 9 | 0.160 |
Why?
| | Aneurysm | 1 | 2014 | 15 | 0.160 |
Why?
| | Hearing | 1 | 2014 | 15 | 0.160 |
Why?
| | Hearing Loss | 1 | 2014 | 19 | 0.160 |
Why?
| | Databases, Factual | 1 | 2016 | 294 | 0.160 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 47 | 0.160 |
Why?
| | tau Proteins | 1 | 2014 | 136 | 0.160 |
Why?
| | False Negative Reactions | 1 | 2013 | 16 | 0.160 |
Why?
| | Brain Injuries | 1 | 2014 | 56 | 0.160 |
Why?
| | Taiwan | 1 | 2013 | 9 | 0.160 |
Why?
| | Neurofibrillary Tangles | 1 | 2014 | 156 | 0.150 |
Why?
| | Biomedical Research | 1 | 2014 | 80 | 0.150 |
Why?
| | Animals | 5 | 2014 | 4859 | 0.150 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 25 | 0.150 |
Why?
| | Magnetic Resonance Imaging, Interventional | 1 | 2013 | 8 | 0.150 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 59 | 0.150 |
Why?
| | Psychometrics | 1 | 2014 | 247 | 0.150 |
Why?
| | Patient Selection | 2 | 2015 | 235 | 0.150 |
Why?
| | Neurosurgical Procedures | 1 | 2015 | 153 | 0.150 |
Why?
| | Hospitalization | 1 | 2015 | 283 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 126 | 0.140 |
Why?
| | Pilot Projects | 1 | 2013 | 391 | 0.140 |
Why?
| | Angioplasty | 2 | 2010 | 14 | 0.140 |
Why?
| | Ductus Arteriosus | 1 | 2011 | 1 | 0.130 |
Why?
| | Fetal Diseases | 1 | 2011 | 10 | 0.130 |
Why?
| | Foramen Ovale, Patent | 1 | 2011 | 10 | 0.130 |
Why?
| | Heart Aneurysm | 1 | 2011 | 11 | 0.130 |
Why?
| | Injections, Intra-Arterial | 1 | 2011 | 15 | 0.130 |
Why?
| | Transportation of Patients | 1 | 2011 | 10 | 0.130 |
Why?
| | Thromboembolism | 1 | 2011 | 37 | 0.130 |
Why?
| | Kidney | 1 | 2013 | 187 | 0.130 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2011 | 22 | 0.130 |
Why?
| | Suction | 1 | 2011 | 42 | 0.130 |
Why?
| | Cross-Sectional Studies | 1 | 2013 | 777 | 0.120 |
Why?
| | Antifibrinolytic Agents | 1 | 2011 | 19 | 0.120 |
Why?
| | Assisted Circulation | 1 | 2010 | 6 | 0.120 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 51 | 0.120 |
Why?
| | Chicago | 1 | 2013 | 803 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 176 | 0.120 |
Why?
| | Hypothermia, Induced | 1 | 2010 | 23 | 0.120 |
Why?
| | Angioplasty, Balloon | 1 | 2009 | 25 | 0.120 |
Why?
| | Vasoconstriction | 1 | 2009 | 20 | 0.110 |
Why?
| | Logistic Models | 1 | 2010 | 453 | 0.110 |
Why?
| | Radiography | 1 | 2011 | 693 | 0.110 |
Why?
| | Risk Factors | 1 | 2016 | 2272 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2010 | 608 | 0.110 |
Why?
| | Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.110 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2008 | 2 | 0.110 |
Why?
| | Human Growth Hormone | 1 | 2008 | 5 | 0.110 |
Why?
| | Prospective Studies | 1 | 2013 | 1562 | 0.110 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2008 | 7 | 0.110 |
Why?
| | Intracranial Thrombosis | 1 | 2008 | 9 | 0.110 |
Why?
| | Medicine | 1 | 2008 | 9 | 0.100 |
Why?
| | Specialization | 1 | 2008 | 14 | 0.100 |
Why?
| | Infant | 2 | 2014 | 590 | 0.100 |
Why?
| | Age Factors | 1 | 2010 | 816 | 0.100 |
Why?
| | Education, Medical | 1 | 2008 | 37 | 0.100 |
Why?
| | Child, Preschool | 2 | 2014 | 746 | 0.100 |
Why?
| | Teaching | 1 | 2008 | 62 | 0.100 |
Why?
| | Radiotherapy Dosage | 2 | 2018 | 145 | 0.090 |
Why?
| | Recovery of Function | 1 | 2008 | 288 | 0.090 |
Why?
| | Convection | 1 | 2005 | 1 | 0.090 |
Why?
| | Osmosis | 1 | 2005 | 8 | 0.090 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 53 | 0.090 |
Why?
| | Aortography | 1 | 2004 | 13 | 0.080 |
Why?
| | Trauma Centers | 1 | 2004 | 11 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 485 | 0.080 |
Why?
| | Kidney Function Tests | 2 | 2013 | 26 | 0.070 |
Why?
| | Lactic Acid | 1 | 2002 | 16 | 0.070 |
Why?
| | Publication Bias | 1 | 2002 | 8 | 0.070 |
Why?
| | Oxygen Consumption | 1 | 2002 | 58 | 0.070 |
Why?
| | Glomerular Filtration Rate | 2 | 2013 | 72 | 0.070 |
Why?
| | Rats | 1 | 2005 | 936 | 0.070 |
Why?
| | Physical Fitness | 1 | 2002 | 49 | 0.070 |
Why?
| | Angiography | 1 | 2002 | 43 | 0.070 |
Why?
| | Heart Rate | 1 | 2002 | 147 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2002 | 364 | 0.070 |
Why?
| | Spinal Cord Diseases | 1 | 2002 | 50 | 0.060 |
Why?
| | Infant, Newborn | 2 | 2014 | 652 | 0.060 |
Why?
| | Malocclusion, Angle Class III | 1 | 2018 | 1 | 0.050 |
Why?
| | Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.050 |
Why?
| | Cephalometry | 1 | 2018 | 4 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2017 | 24 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2018 | 122 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2017 | 25 | 0.050 |
Why?
| | Survival Rate | 1 | 2018 | 403 | 0.050 |
Why?
| | Osteotomy | 1 | 2018 | 130 | 0.050 |
Why?
| | Mice | 2 | 2014 | 1666 | 0.050 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 445 | 0.050 |
Why?
| | Cerebral Infarction | 1 | 2017 | 142 | 0.050 |
Why?
| | Brain | 1 | 2005 | 1251 | 0.050 |
Why?
| | Reperfusion | 1 | 2015 | 12 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2017 | 305 | 0.040 |
Why?
| | Aquaporin 4 | 1 | 2014 | 12 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2014 | 64 | 0.040 |
Why?
| | Speech Disorders | 1 | 2014 | 13 | 0.040 |
Why?
| | Nerve Degeneration | 1 | 2014 | 50 | 0.040 |
Why?
| | Time Factors | 2 | 2011 | 1713 | 0.040 |
Why?
| | Forecasting | 1 | 2014 | 123 | 0.040 |
Why?
| | Disease Management | 1 | 2015 | 119 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2014 | 63 | 0.040 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 73 | 0.040 |
Why?
| | Iohexol | 1 | 2013 | 5 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2014 | 350 | 0.040 |
Why?
| | Radiography, Interventional | 1 | 2013 | 25 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 468 | 0.040 |
Why?
| | Biopsy | 1 | 2013 | 267 | 0.030 |
Why?
| | Contrast Media | 1 | 2013 | 143 | 0.030 |
Why?
| | Comorbidity | 1 | 2013 | 481 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2011 | 88 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 87 | 0.030 |
Why?
| | Ultrasonography | 1 | 2011 | 184 | 0.030 |
Why?
| | Registries | 1 | 2011 | 158 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 19 | 0.030 |
Why?
| | Carotid Arteries | 1 | 2009 | 46 | 0.030 |
Why?
| | Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.030 |
Why?
| | Cyclin D | 1 | 2008 | 1 | 0.030 |
Why?
| | Acute Disease | 1 | 2009 | 258 | 0.030 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 3 | 0.030 |
Why?
| | Cyclins | 1 | 2008 | 6 | 0.030 |
Why?
| | Symporters | 1 | 2008 | 6 | 0.030 |
Why?
| | United States | 1 | 2015 | 2083 | 0.030 |
Why?
| | Hepatocytes | 1 | 2008 | 11 | 0.030 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 16 | 0.030 |
Why?
| | Ligation | 1 | 2008 | 36 | 0.030 |
Why?
| | Liver Regeneration | 1 | 2008 | 25 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2008 | 124 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2008 | 293 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2008 | 210 | 0.020 |
Why?
| | Up-Regulation | 1 | 2008 | 189 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 962 | 0.020 |
Why?
| | Cohort Studies | 1 | 2008 | 1601 | 0.020 |
Why?
| | Myelography | 1 | 2002 | 10 | 0.020 |
Why?
| | Arteriosclerosis | 1 | 2002 | 17 | 0.020 |
Why?
| | Aortic Aneurysm | 1 | 2002 | 16 | 0.020 |
Why?
| | Obesity, Morbid | 1 | 2002 | 68 | 0.020 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|